𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B

✍ Scribed by Okuhara, Sadahisa; Umemura, Takeji; Joshita, Satoru; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Ota, Masao; Tanaka, Eiji


Book ID
121741119
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
252 KB
Volume
44
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Correlation of serum hepatitis B surface
✍ Myoung Hee Lee; Da Mi Lee; Soon Sun Kim; Jae Youn Cheong; Sung Won Cho πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 2 views

## Abstract Recent studies have suggested that quantifying the serum HBsAg levels can predict the response to pegylated interferon. We aimed to determine the change in serum HBsAg levels during entecavir (ETV) treatment and the correlation with treatment response in chronic HBeAg‐positive and HBeAg

Effect of corticosteroid therapy on leve
✍ Maria H. Sjogren; Jay H. Hoofnagle; Jeanne G. Waggoner πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 405 KB πŸ‘ 2 views

## Serum levels of antibody to hepatitis B core antigen and IgM antibody to hepatitis B core antigen were tested in 15 patients who participated in a randomized, placebo-controlled trial of a 28-day course of prednisolone therapy. During treatment, serum levels of antibody to hepatitis B core anti